Pharmaco-EEG: A History of Progress and a Missed Opportunity

Fink M. Quantitative electroencephalography. II Drug patterns. In: Glaser G , (ed). EEG and Behavior. New York: Basic Books; 1963: 177–179.

Itil TM Psychotropic Drugs and the Human EEG. Basel: Karger; 1974.

Itil TM Anticholinergic drug-induced sleep-like EEG pattern in man. Psychopharmacologia 1969; 14(5): 383–393.

Fink M Shapiro DM Itil TM EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers. Psychopharmacologia 1971; 22(4): 369–383.

Fink M Irwin P Weinfeld R Schwartz M Conney A. Blood levels and EEG effects of diazepam and bromazepam. Clin Pharm Therap 1976; 20: 184–191.

Matejcek M. Pharmaco-electroencephalography: The value of quantified EEG in psychopharmacology. Pharmakopsychiat 1979; 15: 126–136.

Sannita WG Benefits of placebos. Nature 1995; 378: 125.

Sannita WG Maggi L Rosadini G. Effects of scopolamine (0.25–0.75 mg im) on the quantitative EEG and the neuropsychological status of healthy volunteers. Neuropsychobiology 1987; 17: 199–205.

Itil TM Shapiro DM Herrmann WM Schulz W Morgan V. HZI systems for EEG parametrization and classification of psychotropic drugs. Pharmakopsychiatr Neuropsychopharmakol 1979; 12: 4–19.

Herrmann WM Schaerer E. Pharmaco-EEG: Computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In: Lopes da Silva FH Storm van Leeuwen W Rémond A , (eds). Handbook of Electroencephalography and Clinical Neurophysiology. Amsterdam: Elsevier; 1982; 2: 385–445.

Saletu B. The use of pharmaco-EEG in drug profiling. In: Hindmarch I Stonier PD , (eds). Human Psychopharmacology Measures and Methods. New York: John Wiley; 1987; 1: 173–200.

Itil TM The discovery of antidepressant drugs by computer-analyzed human cerebral bio-electrical potentials (CEEG). Prog Neurobiol 1983; 20(3–4): 185–249.

Itil TM Cora R Akpinar S Herrmann WM Patterson CJ “Psychotropic” action of sex hormones: Computerized EEG in establishing the immediate CNS effects of steroid hormones. Curr Ther Res Clin Exp 1974; 16(11): 1147–1170.

Fink M Irwin P. Central nervous system effects of aspirin. Clin Pharmacol Ther 1982; 32(3): 362–365.

Lopes da Silva F Pharmaco-EEG: From cellular to the network level. EEG beta spectral power as a biomarker for GABAergic inhibition and its role in the assessment of AEDs. Methods Find Exp Clin Pharmacol 2002; 24(suppl D): 3.

International Pharmaco-EEG group (IPEG). Recommendations for EEG and evoked potential mapping. Neuropsychobiology 1989; 22(3): 170–176.

Abt K. Descriptive data analysis: A concept between confirmatory and exploratory data analysis. Meth Inform Med 1987; 26: 77–88.

Lehmann D Wackermann J Michel CM Koenig T. Space-oriented EEG segmentation reveals changes in brain electric field maps under the influence of a nootropic drug. Psychiatry Res 1993; 50(4): 275–282.

Wackermann J Lehmann D Dvorak I Michel CM Global dimensional complexity of multi-channel EEG indicates change of human brain functional state after a single dose of a nootropic drug. Electroencephalogr Clin Neurophysiol 1993; 86(3): 193–198.

Saletu B Anderer P Kinsperger K Grunberger J. Topographic brain mapping of EEG in neuropsychopharmacology. II. Clinical applications (pharmaco EEG imaging). Methods Find Exp Clin Pharmacol 1987; 9: 385–408.

Maurer K Dierks T Laux G Rupprecht R Ihl R. Topographic mapping of EEG and auditory evoked P300 in neuropsychopharmacology (topographic pharmaco-EEG and pharmaco-AEP 300). Pharmacopsychiatry 1988; 21(6): 338–342.

Pascual-Marqui RD Standardized low-resolution brain electromagnetic tomography (sLORETA): Technical details. Methods Find Exp Clin Pharmacol 2002; 24(suppl D); 5–12.